A transversal presence in the
pharmaceutical market

WHO ARE WE?

FHC | Farmacêutica is a global supplier of healthcare products and a worldwide reference in the supply chain of medicinal products and other healthcare products and a full-liner operator of products and logistic solutions in the sector.

FHC | Farmacêutica leads FHC Group, holding a set of subsidiaries, that act transversally in the human health area.

A global group

At FHC Group, we are passionate about developing, manufacturing, distributing and providing excellence services in the pharmaceutical sector, as part of a global holistic commitment of contributing to the improvement of the pharmaceutical sector, based on the updated and integrated experience, as well as on the knowledge of the companies of the group operating in the sector for more than 70 years.

Our history

1998

Constitution of FHC Farmacêutica

2001

Entrance in the share capital of Empifarma

Entrance in the share capital of Overpharma

2003

Expansion of FHC Farmacêutica logistics facilities to 1,500 m³, in Mortágua

2004

Acquisition of financial participation in Laboratórios Basi and beginning of products distribution in the national market

2005

Constitution of Phagecon, a company dedicated to providing services to the pharmaceutical sector

2007

Acquisition of the total capital of Laboratórios BASI

Creation of Actrádia, S.A, a company dedicated to the management of the group’s real estate assets

Transformation of Empifarma in a public limited company and beginning of the pre-wholesale operation

2008

Constitution of Zeone, a company dedicated to the provision of services and consultancy in the IT area

2010

Construction of a Quality Control laboratory for Laboratórios Basi, with GMP approval, in Mortágua

2011

Construction of the new Liquid and Semi-solid Production Unit of Laboratórios Basi, in Mortágua

Constitution of Actrádia Consultoria, a company dedicated to providing shared services

Acquisition of the total capital of Paracélsia

2014

Development, by Zeone, of the B2B software Magium Farma

Empifarma acquires a Knapp's robotic logistics unit, with 9,000 m2 of covered area, in Montemor-o-Velho and begins the operation of general distribution (pharmacies) and promotion through Magium

2015

Acquisition of 100% of the company Laphysan (Spain), a company dedicated to the distribution and marketing of pharmaceutical products

Design of the Project for the Production Unit of Injections of Laboratórios Basi, in Mortágua

2017

Construction of the Production Unit of Injections of Laboratórios Basi in Mortágua

2019

Manufacturer’s Authorisation (EudraGMP) for the Production unit of Injections of Laboratórios Basi, in Mortágua

Empifarma completes the expansion project of a new Knapp’s robotic logistics unit, in Famões (Lisbon)

2020

FHC, having a deep knowledge in the pharmaceutical supply chain, allowed a quick and effective action in the response to COVID-19, supplying the necessary equipment to several countries and national health authorities to contain the spread of the virus

Basi became members of iBET – Instituto de Biologia Experimental e Tecnológica and obtained certification in Quality (NP EN ISO 9001:2015), Environment (NP BN ISO 14001:2015) and Safety (ISO 4500:2018)

Constitution of Basinnov Life Sciences

2021

Implementation of the ISO 50001:2018 Energy Management Process, in Basi

Basi obtained Recognition of Suitability in terms of Research and Development, by ANI

Acquisition of a financial stake in the company Mozpharma (MZ)

2022

Basi announces a strategic investment and partnership with TargTex, a private biotechnology company which develops an innovative and novel treatment for brain tumours

Basi and Beta-i • collaborative innovation launches global co-innovation program for oncology and immunotherapy

Creation of Pharma Academy, Training Academy

Requalification of the Headquarters Building of the FHC Group

Acquisition of a financial stake in the company Grasshopper (PT)

Constitution of SVP Pharma (UK)

Constitution of Guinepharma (GE)

Constitution of Vitamed (BR)

2023

Acquisition of a financial stake in the company Worldrugs (PT)

Acquisition of a financial stake in the company Socifarma (AO)

Acquisition of a financial stake in the company Mecofama (AO)

Disposal of a financial stake in the company Phagecon (PT)

Disposal of a financial stake in the company Saluspharma (GW e ST)

FHC Group in numbers

Forecast Aggregate Financial Indicators 2023

0 M€
Turnover
0 M€
Equity
0 M€
EBITDA
0
Employees

Areas of Activity

In the last 25 years, the group has accumulated relevant experience in several areas of the pharmaceutical sector, developing its business activity in the Health sector, focusing in all pharmaceutical value chain.

Clinical
Investigation

Innovation
in Technology

Manufacturing
.

Logistics
& Distribution

Retail
.

Consultancy
.

Where are we?

We actively work for unmet needs of patients and consumers on a global scale, making healthcare products affordable, contributing to the health and well-being of millions of people in more than 60 countries.

We are present directly in 7 geographies, which allows us to operate in an integrated way in these markets, from consulting and monitoring services in Pharmaceutical Regulatory Affairs, to promotion and local Logistics & Distribution operations.
BRAZIL
Vitamed
SPAIN
MOZAMBIQUE
UNITED KINGDOM
SVP Pharma
  • EXPORT
  • MANUFACTURING CONTRACT
  • PORTFOLIO (OWN PRODUCTS)
  • MANUFACTURING LICENSE
AMERICA
AFRICA
EUROPE
ASIA
BRAZIL
Peru
Venezuela
South Africa
Angola
Burkina Faso
Cape Green
Cameroon
Ivory Coast
Ethiopia
Gabon
Ghana
Equatorial Guinea
Guinea Bissau
Guinea Conakry
Libya
Madagascar
Mauritius
Mauritania
Mozambique
Nigeria
Kenya
Dem. Rep. of Congo
Republic of Congo
S. Tomé & Príncipe
Senegal
Tunisia
Uganda
Albania
Germany
Armenia
Austria
Belgium
Cyprus
Croatia
Denmark
Slovakia
Slovenia
Spain
France
Georgia
The Netherlands
Hungary
Ireland
Italy
Kosovo
Latvia
Lithuania
Luxembourg
Macedonia
Moldavia
Poland
Portugal
United Kingdom
Czech Republic
Romania
Serbia
Sweden
Ukraine
Azerbaijan
Qatar
Hong Kong
Iran
Iraq
Israel
Jordan
Kuwait
Lebanon
Macao
Kyrgyzstan
East Timor
Uzbekistan
Vietnam
  • EXPORT
  • MANUFACTURING CONTRACT
  • PORTFOLIO (OWN PRODUCTS)
  • MANUFACTURING LICENSE
AMERICA
BRAZIL
Peru
Venezuela
AFRICA
South Africa
Angola
Burkina Faso
Cape Green
Cameroon
Ivory Coast
Ethiopia
Gabon
Ghana
Equatorial Guinea
Guinea Bissau
Guinea Conakry
Libya
Madagascar
Mauritius
Mauritania
Mozambique
Nigeria
Kenya
Dem. Rep. of Congo
Republic of Congo
S. Tomé & Príncipe
Senegal
Tunisia
Uganda
EUROPE
Albania
Germany
Armenia
Austria
Belgium
Cyprus
Croatia
Denmark
Slovakia
Slovenia
Spain
France
Georgia
The Netherlands
Hungary
Ireland
Italy
Kosovo
Latvia
Lithuania
Luxembourg
Macedonia
Moldavia
Poland
Portugal
United Kingdom
Czech Republic
Romania
Serbia
Sweden
Ukraine
ASIA
Azerbaijan
Qatar
Hong Kong
Iran
Iraq
Israel
Jordan
Kuwait
Lebanon
Macao
Kyrgyzstan
East Timor
Uzbekistan
Vietnam

WHAT DO WE DO?

FHC | Farmacêutica is a global supplier of healthcare products and a worldwide reference in the distribution chain of medicinal products, medical devices and other healthcare products.

We have a deep knowledge and a wide network in the pharmaceutical sector, allowing us to have a broad global vision and to provide a wide spectrum of healthcare products suited to the needs of each market and under the best conditions, enabling the treatment of millions of people across the world.

Pharmaceutical Products

Medical
Devices

Medical Equipment

Diagnostic Material

Medical
Instruments

At FHC | Farmacêutica, we also ensure the complete management of the supply chain of pharmaceutical products in the external markets where we operate, in accordance with “Good Distribution Practices” established in the European Union.

The excellence and quality of what we do, allowed us to build a relationship of great trust with our clients and partners.

Our mission

To be a global company, to aggregate and to enhance knowledge and synergies generated within the group and to provide a unique value offer to clients and partners. To be recognized as a leading reference company within the scope of our action.

We believe that the access to quality and affordable healthcare is everyone’s right. We contribute to improve the access to quality healthcare for millions of people around the world.

Our values

Integrity

All of our decisions are determined by ethically correct principles

Values

Our clients are at the heart of everything we do and our success comes from their success

Commitment

We take personal responsibility for our work and our actions

Respect

We treat everyone with dignity, consideration, transparency and respect

Excellence

We always look for the best for our organization, clients and partners

Installed capacity

FHC | Farmacêutica

0
SKU's
0
Locations / Racks
0
Cold Volume
0
Warehouse Management System
0
Exported Tons
0
Loaded Containers
0
Storage Area
0 M
Sold Units

Financial Information

Strong growth.
Successful strategy.
Because we believe in what we do. Our driving force is the passion for challenge, energy and belief. Our commitment is to remain true to our principles focused on the continuous improvement of our processes and the simplification of our operations.

We exist to create sustainable value.

why fhc?

Knowledge

The 25 years of experience with the demand and the diversity of requirements of the markets where we operate associated with the vast knowledge generated within the group, allow us to have the best solutions and answer with a level of service of reference to our clients, partners and suppliers.

Access to quality healthcare

Within the group, we have a highly specialised procurement team and a vast network with the main players that, associated with the synergies generated within the group, allow us to have a unique ability to respond to the needs and specifications of each market.

Our presence

We currently have direct presence in seven geographies, in which we have a complete service solution - integrated logistics, local distribution and promotion.

Level of service

The permanent stock of approximately 15,000 SKUs, adequate to the needs and specifications of the markets where we operate, associated with our installed capacity, allows us to have the best response level.

Our B2B Portal allows to visualise, on time, the status of client’s orders, check shipments and have access to the documentation, verify the movements and have access to all documents of their current account.

Trust

We have built, along more than 25 years, a high level of trust among all stakeholders. Our reputation is undoubtedly a guarantee and a determining factor for those who work with us.

Quality, environment and safety

Pharmaceutical distribution is a sector of enormous complexity and whose demands require a daily response in full harmony with the best practices available in the market.

With a consolidated international presence, we recognize that the impacts associated with the life cycle of our activity are particularly relevant.

Our greatest strength lies in the detailed knowledge of the markets and the quality of the products sold.

It is on these assumptions that FHC bases its sustainability strategy, guaranteeing the necessary balance to satisfy the needs of its customers, while promoting a socially responsible and environmental protection policy.

To this end, we highlight 5 areas in which we are more clearly committed:
Commitment to its human resources as a clearly differentiating factor due to its quality, delivery and vision;
Optimization of the distribution chain, enhancing the cargo transported and the defined route;
Promotion of circular economy principles, ensuring the extension of the useful life of materials and the selection of products with incorporated recycled material and with less environmental impact;
Energy management of facilities, through the definition of means of proximity control in order to ensure efficient use of available resources.

An ambitious project to produce energy for self-consumption is under way, which will allow us to significantly reduce dependence on non-renewable resources.

In early 2023, FHC successfully completed the certification process for the ISO 14001 – Environmental Management and ISO 45001 – Occupational Health and Safety Management standards, now having, together with the certification in Quality Management – ISO 9001, a Integrated Management System, which will allow us to reinforce the efficiency of the organization's internal processes and responses to the numerous requests we are confronted with.

We know our value and the extent to which our contribution can go, whether in the operation we develop or in the capacity for influence that we seek to promote with our partners, which is why we remain committed to significantly advancing the goal of carbon neutrality.

For each new goal achieved, we renew our responsibility and ambition to do even more and better.

We are permanently focused on continuously improving our performance, aimed at:

Ensure the client's satisfaction through a variety of customised services and the offer of innovative, quality, safe, effective products, that meet the wanted performance or claim;

Optimise the performance of the processes and of the Management System through the best possible use of the resources and technologies available and through effective planning, in order to obtain business and energy performance advantage;

Distribute resources effectively for the performance of the internal activities, in order to promote creation of value for the shareholders ensuring continuous monitoring of the economic-financial performance and continuously promoting the improvement of the internal processes in order to obtain productivity and improvement of the energy performance;

Promotion of the continuous improvement in the performance of the Management System and its processes, through the optimisation of the allocation of the resources and technologies available as well as the use of the best planning practices;

Anticipate and diversify, through permanent control, close to the market, in order to continuously adapt the offer of products and services in accordance with its needs, allowing the implementation of an activity oriented to the “innovation at the client’s service”;

Promote the management of scientific, technological, organisational, financial and commercial (including investment in new technologies) activities, aligned with the implementation of Innovation, supported in the design and acquisition of products and services energetically efficient;

Ensure compliance with legal, regulatory and other requirements that organization subscribes, and compliance with the requirements agreed with stakeholders;

Promote the continuous improvement of the environmental performance, through the identification and control of the environmental aspects controlled by the organisation and through its influence, regarding the offer of products and services, preventing pollution;

Promote the continuous improvement of the Safety and Health at work conditions, through the identification and control of risks and prevention of occurrence of accidents (at work);

Promote the involvement of all employees in the purposes and growth strategies of the company, through the promotion of creativity, communication and activities of collaboration, consultation and participation.

Certifications

contacts

Parque Industrial Manuel Lourenço Ferreira,
Lote 2/10, Apartado 45
3450-232 Mortágua
Portugal